]>
IRCT20170912036157N2 IRCT 2020-05-19 Iran University of Medical Sciences Assessment of response to treatment in anemia (iron deficiency) after CABG in adults Assessment of response to treatment in anemia (iron deficiency) after CABG in adults 2020-04-19 anticipated 142 Complete https://irct.ir/trial/48115 interventional Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: In this study, a person who is responsible for analyzing statistical data is not aware of the treatment process and study groups and the information is provided to that person in groups A and B. This helps the person's personal opinion not to affect the results. 3 Chronic ischemic heart disease. Intervention group: In this study, each patient is placed in the control group first and enters the intervention group after the intervention.First, patients are tested for ferritin, TIBC, and reticulocytes. Oral therapy (ferrous sulfate) 60 mg three times a day is started based on the results of experiments to treat iron deficiency anemia. The above tests are repeated one week later to evaluate the treatment. If the response to treatment is appropriate, the patient will be monitored once and up to three times a month for CBC, TIBC, ferritin, and reticulocytes. Injectable iron is used at a dose of 200 mg intravenously slowly over 2,5 minutes and five times at intervals of 14 days if the tests are not appropriate one week after the start of oral iron, and the same follow-up is performed quarterly.. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Zia Totonchi
Iran University of Medical Sciences., Hemmat Highway., Next to Milad Tower., Tehran Town
Tehran Iran (Islamic Republic of) 1433933111 +98 21 2392 2153 ziya189@yahoo.com Iran University of Medical Sciences scientific Zia Totonchi
Iran University of Medical Sciences., Hemmat Highway., Next to Milad Tower., Tehran Town
Tehran Iran (Islamic Republic of) 1433933111 +98 21 2392 2153 ziya189@yahoo.com Iran University of Medical Sciences Iran (Islamic Republic of) Age between 18 until 72 years Patients are candidates for CABG for the first time Hemoglobin is less than 10 in women and less than 11 in men 18 years 72 years Both History of previous surgery Kidney disorders Autoimmune diseases Bleeding disorders, Thalassemia I25 Chronic ischemic heart disease Treatment - Drugs Intervention group: In this study, each patient is placed in the control group first and enters the intervention group after the intervention.First, patients are tested for ferritin, TIBC, and reticulocytes. Oral therapy (ferrous sulfate) 60 mg three times a day is started based on the results of experiments to treat iron deficiency anemia. The above tests are repeated one week later to evaluate the treatment. If the response to treatment is appropriate, the patient will be monitored once and up to three times a month for CBC, TIBC, ferritin, and reticulocytes. Injectable iron is used at a dose of 200 mg intravenously slowly over 2,5 minutes and five times at intervals of 14 days if the tests are not appropriate one week after the start of oral iron, and the same follow-up is performed quarterly. Hemoglobin level. Timepoint: Before and after treatment. Method of measurement: Blood test. Ferritin level. Timepoint: Before and after treatment. Method of measurement: blood test. Iran University of Medical Sciences Approved 2020-04-19 Ethics committee of Iran University of Medical Sciences Iran University of Medical Sciences., Hemmat Highway., Next to Milad Tower., Tehran Town Tehran Tehran Iran (Islamic Republic of)